research use only

PR-171 (Carfilzomib) Proteasome Inhibitor

Cat.No.: S2853

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the β5 subunit, but little or no effect on the PGPH and T-L activities. Carfilzomib activates prosurvival autophagy and induces cell apoptosis.
Jump to

Quality Control

Batch: Purity: 99.75%
99.75

Solubility in DMSO or water

In vitro
Batch:

DMSO : 100 mg/mL (138.9 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 50 mg/mL

Water : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about PR-171 (Carfilzomib) solubility in DMSO or water

Working concentrations for cell culture treatment

Search by Cell Line | Choose a Research Area to Find Working Concentrations

Read more about PR-171 (Carfilzomib) working concentrations for cell culture treatment

×

Selectivity & Specificity

PR-171 (Carfilzomib) is a potent inhibitor of 20S immunoproteasome (iCP) (8.1 nM), 20S proteasome β5 subunit (6 nM), 20S proteasome β1 subunit (2400 nM), 20S proteasome β2 subunit (3600 nM), 20S proteasome catalytic subunit β1 (2400 nM), 20S proteasome catalytic subunit β2 (3600 nM), 20S proteasome catalytic subunit β5 (6 nM), 20S proteasome, 20S proteasome (chymotrypsin-like activity), Proteasome β5 subunit (CT-L activity) (6 nM), Proteasome β1 subunit (C-L activity) (2400 nM), Proteasome β2 subunit (T-L activity) (3600 nM), Relapsed/refractory multiple myeloma, Glioblastoma, Lung cancer, Refractory renal cancer, Metastatic prostate cancer, VD, CVAE, Cardiac failure, Ischemic heart disease, Hypertension, AF, CAD, TMA. PR-171 (Carfilzomib) exhibits the greatest inhibitory potency toward 20S proteasome β5 subunit (IC50 = 6 nM).

Selectivity & Specificity Details

Mechanism of Action

Information PR-171 (Carfilzomib) is a potent, selective, and irreversible 20S proteasome inhibitor. It affects NF-κB and apoptotic signaling by binding to the β5 subunit to block polyubiquitinated protein degradation, effectively inducing apoptosis and inhibiting tumor cell proliferation.

Read more about PR-171 (Carfilzomib) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about PR-171 (Carfilzomib) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 719.91 Formula

C40H57N5O7

Storage (From the date of receipt)
CAS No. 868540-17-4 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about PR-171 (Carfilzomib)

Frequently Asked Questions

Question 1:
How should I prepare a solution of it for an ongoing in vivo study?

Answer:
It can be dissolved in 2% DMSO/30% PEG 300/dd H₂O at 10 mg/ml as a suspension, and can be dissolved in 2% DMSO/castor oil at 10 mg/ml as a clear solution.